Sp821
UPDATED GUIDELINES IN BARRETT'S ESOPHAGUS: WHERE DO WE GO NEXT?
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
Barrett's esophagus is the only precancerous condition for esophageal adenocarcinoma; a cancer that is associated with rising incidence and high morbidity and mortality rates. This session will highlight the recent advances, controversies and knowledge gaps in the field of screening, surveillance and endoscopic eradication therapies. This session will also include a presentation on the current status and future directions for quality metrics in Barrett's esophagus.
Barrett's esophagus is the only precancerous condition for esophageal adenocarcinoma; a cancer that is associated with rising incidence and high morbidity and mortality rates. This session will highlight the recent advances, controversies and knowledge gaps in the field of screening, surveillance and endoscopic eradication therapies. This session will also include a presentation on the current status and future directions for quality metrics in Barrett's esophagus.
Presenter
University of Colorado
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
BARRETT'S ESOPHAGUS
This 90 minute session is designed to link junior faculty/GI fellows/other trainees who are interested in pursuing a clinical/research career in diseases of the upper gastrointestinal tract with established clinician/researcher experts in the field…
MAGNITUDE OF POST-ENDOSCOPY ESOPHAGEAL ADENOCARCINOMA (PEEC) AND POST-ENDOSCOPY ESOPHAGEAL NEOPLASIA (PEEN) IN A POPULATION-BASED COHORT STUDY – THE NORDIC BARRETT’S ESOPHAGUS STUDY (NORDBEST)
Barrett’s esophagus (BE), a pre-malignant precursor of esophageal adenocarcinoma (EAC), when recognized early through screening, could potentially allow for endoscopic surveillance or endoscopic eradication therapy…
